• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗结核药物与其他抗菌药物联合增强活性]

[Enhancement of the activity of antitubercular agents with other antimicrobial agents].

作者信息

Vinogradova T I

出版信息

Probl Tuberk. 1994(3):59-62.

PMID:7937678
Abstract

The experimental studies have provided strong evidence that the efficacy of etiotropic therapy for tuberculosis can be enhanced by applying a number of antimicrobial agents having different mechanism of action, which belong to cephalosporins, macrolides, aminoglycosides, fluoroquinolones. The basis of the mechanism responsible for potentiation of activity of essential tuberculostatic drugs for potentiation of activity of essential tuberculostatic drugs is enhanced inhibition of the viability of a microbacterial population, prevented development of drug resistance in tuberculosis mycobacteria, and increased function of macrophages.

摘要

实验研究提供了强有力的证据,表明通过应用多种作用机制不同的抗菌药物(属于头孢菌素类、大环内酯类、氨基糖苷类、氟喹诺酮类),可以提高针对结核病的病因疗法的疗效。增强基本抗结核药物活性的机制基础是增强对微生物群体生存能力的抑制、防止结核分枝杆菌产生耐药性以及增强巨噬细胞功能。

相似文献

1
[Enhancement of the activity of antitubercular agents with other antimicrobial agents].[抗结核药物与其他抗菌药物联合增强活性]
Probl Tuberk. 1994(3):59-62.
2
[Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].[抗鸟分枝杆菌复合群感染治疗药物的临床前研究——特别提及新型大环内酯类和新型喹诺酮类药物]
Kekkaku. 1996 Sep;71(9):531-5.
3
Fluoroquinolones: a new treatment for tuberculosis?
Int J Tuberc Lung Dis. 1998 Apr;2(4):265-71.
4
[Immunotropic activity of antimicrobial agents used in tuberculosis].[用于结核病的抗菌药物的免疫调节活性]
Probl Tuberk. 1996(2):43-5.
5
[Etiotropic therapy of brucellosis].
Antibiot Khimioter. 1998;43(3):37-42.
6
Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.新型抗分枝杆菌药物的研发前景,特别提及新型苯并恶嗪利福霉素KRM-1648
Arch Immunol Ther Exp (Warsz). 2000;48(3):183-8.
7
[A study on drug regimens against Mycobacterium avium-intracellulare infection (3). The therapeutic effect of some antimicrobial agents to murine infection model].
Kekkaku. 1988 Jun;63(6):447-60.
8
[The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].[结核病与非结核分枝杆菌感染的细菌学]
Rev Mal Respir. 1997 Dec;14 Suppl 5:S33-48.
9
Antibiotics in older adults.老年人使用的抗生素
P R Health Sci J. 2004 Mar;23(1):25-33.
10
[Current antibiotics for clinical practice].[临床实践中的现有抗生素]
Praxis (Bern 1994). 1996 Oct 1;85(40):1240-4.